Primary Care Opioid Taper Plans Are Associated with Sustained Opioid Dose Reduction.

D Sullivan, Mark; Boudreau, Denise; Ichikawa, Laura; Cronkite, David; Albertson-Junkans, Ladia; Salgado, Gladys; VonKorff, Michael; Carrell, David S

D Sullivan, Mark; Boudreau, Denise; Ichikawa, Laura; Cronkite, David; Albertson-Junkans, Ladia; Salgado, Gladys; VonKorff, Michael; Carrell, David S.

Affiliation

D Sullivan M; University of Washington, Seattle, WA, USA. sullimar@uw.edu.
Boudreau D; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
Ichikawa L; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
Cronkite D; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
Albertson-Junkans L; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
Salgado G; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
VonKorff M; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.
Carrell DS; Kaiser Permanente Washington Research Institute, Seattle, WA, USA.

J Gen Intern Med ; 35(3): 687-695, 2020 03.

Article de En | MEDLINE | ID: mdl-31907789

Sujet(s)
Mots clés

case-control study; dose reduction; long-term opioid therapy; natural language processing; opioid discontinuation

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Dossiers médicaux électroniques / Diminution progressive de la dose du médicament / Analgésiques morphiniques Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans Langue: En Journal: J Gen Intern Med Sujet du journal: MEDICINA INTERNA Année: 2020 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google